Surgery vs conservative management of strabismus

Article

Surgery vs conservative management of strabismus

The prevalence of strabismus in infants with high-risk pre-threshold retinopathy of prematurity (ROP) varies significantly during the first year of life, leading to the conclusion that conservative management may be the best approach, according to the results of a trial published in the June issue of Archives of Ophthalmology.

Dr Deborah VanderVeen of the Boston Children's Eye Hospital and Harvard University, USA, led a team of researchers who examined 700 infants, at 26 sites, with high-risk pre-threshold or low-risk ROP for the presence of strabismus. At six months, the prevalence of strabismus was 20.3% in high-risk infants and 9.6% in low-risk infants.

For the high-risk infants, strabismus became more prevalent at nine months (30%) than it was at six months (20.3%). Risk factors at this age included abnormal fixation behaviour, the presence of amblyopia and having been born at centres outside of the study sites.

Dr VanderVeen advised managing the infants non-surgically, prescribing glasses, patching the opposite eye where amblyopia is present, and visual training.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
© 2025 MJH Life Sciences

All rights reserved.